Analysis of the tight skin (Tsk1/+) mouse as a model for testing antifibrotic agents

Laboratory Investigation

Volumn 85, Issue 10, 2005, Pages 1199-1209

  Baxter, Ruth M ^a   Crowell, Thomas P ^a   McCrann, Margaret E ^a   Frew, Erica M ^a   Gardner, Humphrey ^a  

^a BIOGEN   (United States)

Author keywords

Fibrillin; Fibrosis; Scleroderma; Tight skin mouse; Transcript profiling

Indexed keywords

ANTIFIBROTIC AGENT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DERMIS; GENE EXPRESSION PROFILING; MALE; MOUSE; MOUSE STRAIN; NECK; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCLERODERMA; SIGNAL TRANSDUCTION; SKIN FIBROSIS; SKINFOLD THICKNESS; UPREGULATION; WILD TYPE;

ANIMALS; COLLAGEN; DERMIS; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LUNG; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROFILAMENT PROTEINS; MUTATION; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; SCLERODERMA, SYSTEMIC; SEX FACTORS; SIGNAL TRANSDUCTION; SKIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 25144523631     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700331     Document Type: Article

References (44)

1. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein is a component of microfibrils. J Cell Biol 1968;103:2499-2509.
2. Sakai LY, Keene DR. Fibrillin: monomers and microfibrils. Methods Enzymol 1994;245:29-52.
3. Wallis DD, Tan FK, Kessler R, et al. Fibrillin 1 abnormalities in dermal fibroblast cultures from first-degree relatives of patients with systemic sclerosis (scleroderma). Arthritis Rheum 2004;50:329-331.
4. Arnett F, Howard R, Tan F, et al. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 1996;39:1362-1370.
5. Tan FK, Stivers DN, Foster MW, et al. Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population. Arthritis Rheum 1998;41:1729-1737.
6. Fleischmajer R, Jacobs L, Schwartz E, et al. Extracellular microfibrils are increased in localized and systemic scleroderma skin. Lab Invest 1991;64:791-798.
7. Tan FK, Arnett FC, Antohi S, et al. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol 1999;163:1066-1072.
8. Arnett FC, Tan FK, Uziel Y, et al. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin 1, in patients with localized scleroderma. Arthritis Rheum 1999;42:2656-2659.
9. Wallis DD, Tan FK, Kielty CM, et al. Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma). Arthritis Rheum 2001;44:1855-1864.
10. Isogai Z, Ono RN, Ushiro S, et al. Latent transforming growth factor β-binding protein 1 interacts with fibrillin and is a microfibril- associated protein. J Biol Chem 2003;278:2750-2757.
11. Neptune ER, Frischmeyer PA, Arking DE, et al. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003;33:407-411.
12. Unsold C, Hyytiainen M, Bruckner-Tuderman L, et al. Latent TGF-b binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci 2000;114:187-197.
13. Saito S, Nishimura H, Brumeanu T-D, et al. Characterization of mutated protein encoded by partially duplicated fibrillin-1 gene in tight skin (TSK) mice. Mol Immunol 1999;36:169-176.
14. Trojanowska M. Molecular aspects of scleroderma. Front Biosci 2002;7:608-618.
15. Strehlow D, Korn JH. Biology of the scleroderma fibroblast. Curr Opin Rheum 1998;10:572-578.
16. Leask A, Abraham DJ. TGF-b signaling and the fibrotic response. FASEB J 2004;18:816-827.
17. Siracusa LD, McGrath R, Ma Q, et al. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res 1996;6:300-313.
18. Green MC, Sweet HO, Bunker LE. Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am J Pathol 1976;82:493-521.
19. Menton DN, Hess RA, Lichtenstein JR, et al. The structure and tensile properties of the skin of tight-skin (Tsk) mutant mice. J Invest Dermatol 1978;70:4-10.
20. Menton DN, Hess RA. The ultrastructure of collagen in the dermis of tight-skin (Tsk) mutant mice. J Invest Dermatol 1980;74:139-147.
21. Jimenez SA, Millan A, Bashey RI. Scleroderma-like alterations in collagen metabolism occurring in the TSK (tight skin) mouse. Arthritis Rheum 1984;27:180-185.
22. Hatakeyama A, Kasturi KN, Wolf I, et al. Correlation between the concentration of serum anti-topoisomerase I autoantibodies and histological and biochemical alterations in TSK mice. Cell Immunol 1996;167:135-140.
23. Bocchieri MH, Jimenez SA. Animal models of fibrosis. Rheum Dis Clin N Am 1990;16:153-167.
24. Saito S, Kasturi K, Bona C. Genetic and immunologic features associated with scleroderma-like syndrome of TSK mice. Curr Rheumatol Rep 1999;1:34-37.
25. Pablos JL, Everett ET, Norris JS. The tight skin mouse: an animal model of systemic sclerosis. Clin Exp Rheumatol 2004;22:S81-S85.
26. Jimenez SA, Williams CJ, Myers JC, et al. Increased collagen biosynthesis and increased expression of type I and type III procollagen genes in the tight skin (TSK) mouse fibroblasts. J Biol Chem 1986;261:657-662.
27. Pines M, Domb A, Ohana M, et al. Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone. Biochem Pharmacol 2001;62:1221-1227.
28. McGaha TL, Saito S, Phelps RG, et al. Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes. J Invest Dermatol 2001;116:136-143.
29. McGaha TL, Phelps RG, Spiera H, et al. Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor- β-mediated smad3 activatin in fibroblasts. J Invest Dermatol 2002;118:461-470.
30. Kodera T, McGaha TL, Phelps R, et al. Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embyronic death and diminishes TGF-β production by fibroblasts. Proc Natl Acad Sci USA 2002;99:3800-3805.
31. McGaha TL, Bona C. Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma. Autoimmun Rev 2002;1:174-181.
32. Levi-Schaffer F, Nagler A, Slavin S, et al. Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone. J Invest Dermatol 1996;106:84-88.
33. Phelps RG, Murai C, Saito S, et al. Effect of targeted mutation in collagen V alpha 2 gene on development of cutaneous hyperplasia in tight skin mice. Mol Med 1998;4:356-360.
34. Gayraud B, Keene DR, Sakai LY, et al. New insights into the assembly of extracellular microfibrils from the analysis of the fibrillin mutation in the tight skin mouse. J Cell Biol 2000;150:667-679.
35. Lemaire R, Korn JH, Schiemann WP, et al. Fibulin-2 and fibulin-5 alterations in Tsk mice associated with disorganized hypodermal elastic fibers and skin tethering. J Invest Dermatol 2004;123:1063-1069.
36. Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci 2001;114(Part 24):4359-4369.
37. Sundberg JP. The tight-skin (Tsk) mutation, chromosome 2. In: Sundberg JP (ed). Handbook of Mouse Mutations with Skin and Hair Abnormalities. CRC Press Inc.: Boca Raton, FL, 1994, pp 279-283.
38. Markova MS, Zeskand J, McEntee B, et al. A role for the androgen receptor in collagen content of the skin. J Invest Dermatol 2004;123:1052-1056.
39. Lemaire R, Farina G, Kissin E, et al. mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen. Arthritis Rheum 2004;50:915-926.
40. Denton CP, Zheng B, Shiwen X, et al. Activation of a fibroblast specific enhancer of the Proα2(I) collagen gene in tight-skin mice. Arthritis Rheum 2001;44:712-722.
41. Pablos JL, Everett ET, Harley R, et al. Transforming growth factor-β1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse. Lab Invest 1995;72:670-678.
42. Zhu H, Bona C, McGaha TL. Polymorphisms of the TGF-β1 promoter in tight skin (TSK) mice. Autoimmunity 2004;37:51-55.
43. Ong C, Wong C, Roberts CR, et al. Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma. Eur J Immunol 1998;28:2619-2629.
44. McGaha TL, Le M, Kodera T, et al. Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts. Arthritis Rheum 2003;48:2275-2284.